Profusa, Inc. Common Stock (PFSA) is a publicly traded Healthcare sector company. As of July 27, 2026, PFSA trades at $1.70 with a market cap of $1.01M and a P/E ratio of -0.02. PFSA moved +0.00% today. Year to date, PFSA is -99.10%; over the trailing twelve months it is -99.88%. Its 52-week range spans $1.69 to $4,500.00. Rallies surfaces PFSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Profusa Announces 1-for-25 Reverse Split Reducing Outstanding Shares to 530K: Profusa filed an amendment to its charter to execute a one-for-25 reverse stock split of its common stock effective July 7, 2026. The split will consolidate approximately 13.2 million outstanding shares into 530 thousand and provide cash payments in lieu of fractional shares, while authorized shares remain at 601 million.
| Metric | Value |
|---|---|
| Price | $1.70 |
| Market Cap | $1.01M |
| P/E Ratio | -0.02 |
| EPS | $-107.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $4,500.00 |
| 52-Week Low | $1.69 |
| Volume | 23.81K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-35.82M |
| Gross Margin | 0.00% |
PFSA analyst coverage data. Average price target: $0.00.